| Phytoestrogen concentrations in serum from Japanese men and women over forty years of age MS Morton, O Arisaka, N Miyake, LD Morgan, BAJ Evans The Journal of nutrition 132 (10), 3168-3171, 2002 | 372 | 2002 |
| Tamoxifen resistance in MCF7 cells promotes EMT‐like behaviour and involves modulation of β‐catenin phosphorylation S Hiscox, WG Jiang, K Obermeier, K Taylor, L Morgan, R Burmi, D Barrow, ... International journal of cancer 118 (2), 290-301, 2006 | 350 | 2006 |
| Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells S Hiscox, L Morgan, TP Green, D Barrow, J Gee, RI Nicholson Breast cancer research and treatment 97, 263-274, 2006 | 271 | 2006 |
| Tamoxifen resistance in breast cancer cells is accompanied by an enhanced motile and invasive phenotype: Inhibition by gefitinib (Iressa', ZD1839) S Hiscox, L Morgan, D Barrow, C Dutkowski, A Wakeling, RI Nicholson Clinical & experimental metastasis 21, 201-212, 2004 | 151 | 2004 |
| Dual targeting of Src and ER prevents acquired antihormone resistance in breast cancer cells S Hiscox, NJ Jordan, C Smith, M James, L Morgan, KM Taylor, TP Green, ... Breast cancer research and treatment 115, 57-67, 2009 | 88 | 2009 |
| Src kinase promotes adhesion-independent activation of FAK and enhances cellular migration in tamoxifen-resistant breast cancer cells S Hiscox, NJ Jordan, L Morgan, TP Green, RI Nicholson Clinical & experimental metastasis 24, 157-167, 2007 | 87 | 2007 |
| Elevated Src kinase activity attenuates Tamoxifen response in vitro and is associated with poor prognosis clinically. L Morgan, J Gee, S Pumford, L Farrow, P Finlay, J Robertson, I Ellis, ... Cancer biology & therapy 8 (16), 1550-1558, 2009 | 83 | 2009 |
| Mimicking the tumour microenvironment: three different co‐culture systems induce a similar phenotype but distinct proliferative signals in primary chronic lymphocytic leukaemia … E Hamilton, L Pearce, L Morgan, S Robinson, V Ware, P Brennan, ... British journal of haematology 158 (5), 589-599, 2012 | 80 | 2012 |
| Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer S Hiscox, L Morgan, T Green, RI Nicholson Endocrine-related cancer 13 (Supplement_1), S53-S59, 2006 | 66 | 2006 |
| Potential roles of suppressor of cytokine signaling in wound healing Y Feng, AJ Sanders, LD Morgan, KG Harding, WG Jiang Regenerative medicine 11 (2), 193-209, 2016 | 36 | 2016 |
| Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX‐2 C Pepper, JG Mahdi, AGS Buggins, S Hewamana, E Walsby, E Mahdi, ... Cell proliferation 44 (4), 380-390, 2011 | 35 | 2011 |
| SRC as a therapeutic target in breast cancer L Morgan, RI Nicholson, S Hiscox Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug …, 2008 | 28 | 2008 |
| Importance of activated leukocyte cell adhesion molecule (ALCAM) in prostate cancer progression and metastatic dissemination AJ Sanders, S Owen, LD Morgan, F Ruge, RJ Collins, L Ye, MD Mason, ... Oncotarget 10 (59), 6362, 2019 | 18 | 2019 |
| Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasis RJ Collins, LD Morgan, S Owen, F Ruge, WG Jiang, AJ Sanders International journal of cancer 143 (10), 2537-2550, 2018 | 16 | 2018 |
| Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38 L Pearce, L Morgan, TT Lin, S Hewamana, RJ Matthews, S Deaglio, ... haematologica 95 (3), 514, 2010 | 14 | 2010 |
| The influence of leptin on trabecular architecture and marrow adiposity in GH-deficient rats BAJ Evans, MJ Bull, RC Kench, RE Fox, LD Morgan, AE Stevenson, ... Journal of endocrinology 208 (1), 69, 2011 | 13 | 2011 |
| In vitro significance of SOCS-3 and SOCS-4 and potential mechanistic links to wound healing Y Feng, AJ Sanders, LD Morgan, S Owen, F Ruge, KG Harding, WG Jiang Scientific reports 7 (1), 6715, 2017 | 7 | 2017 |
| 406 Reduction of in vitro metastatic potential of tamoxifen-resistant breast cancer cells following inhibition of Src kinase activity by AZD0530 S Hiscox, L Morgan, T Green, R Nicholson EJC Supplements 8 (2), 121-122, 2004 | 3 | 2004 |
| Adverse features of acquired antihormone resistance and their targeting S Hiscox, N Jordan, L Morgan, C Smith, L Goddard, JMW Gee, ... Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer: New …, 2009 | 1 | 2009 |
| Elevated Src kinase activity accompanies endocrine-resistance in breast cancer and promotes an aggressive cell phenotype LD Morgan PQDT-Global, 2007 | 1 | 2007 |
